Skip to main content

/ Cerebral Palsy/ Group items tagged BEAM Trial

Group items tagged

Filter: All | Bookmarks | Topics Simple Middle

Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial) - NICHD - 0 views

clinicaltrials.gov/...NCT00014989

clinical trial clinical trials BEAM Trial antenatal magnesium sulfate research study

shared by Lee Vander Loop on 27 May 10 - Cached

Lee Vander Loop on 27 May 10

As many more premature infants survive, the numbers of these infants with health problems increases. The rate of cerebral palsy (CP) in extremely premature infants is approximately 20%. Magnesium sulfate, the most commonly used drug in the US to stop premature labor, may prevent CP. This trial tests whether magnesium sulfate given to a woman in labor with a premature fetus (24 to 31 weeks out of 40) will reduce the rate of death or moderate to severe CP in the children at 2 years. The children receive ultrasounds of their brains as infants and attend three follow-up visits over two years to assess their health and development.

<div class="cArrow"> </div><div class="cContentInner">As many more premature infants survive, the numbers of these infants with health problems increases. The rate of cerebral palsy (CP) in extremely premature infants is approximately 20%. Magnesium sulfate, the most commonly used drug in the US to stop premature labor, may prevent CP. This trial tests whether magnesium sulfate given to a woman in labor with a premature fetus (24 to 31 weeks out of 40) will reduce the rate of death or moderate to severe CP in the children at 2 years. The children receive ultrasounds of their brains as infants and attend three follow-up visits over two years to assess their health and development.</div>

...

Cancel

1 - 1 of 1

Showing 20▼ items per page

Related searches